Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007;25(6):337-44.
doi: 10.1007/s00774-007-0773-9. Epub 2007 Oct 25.

Involvement of alpha(v)beta3 integrins in osteoclast function

Affiliations
Review

Involvement of alpha(v)beta3 integrins in osteoclast function

Ichiro Nakamura et al. J Bone Miner Metab. 2007.

Abstract

Integrins are heterodimeric adhesion receptors that mediate cell-matrix interaction. Osteoclast exhibits high expression of the alpha(v)beta(3) integrin, which binds to a variety of extracellular matrix proteins including vitronectin, osteopontin, and bone sialoprotein. Arg-Gly-Asp (RGD)-containing peptides, RGD-mimetics, and blocking antibodies to alpha(v)beta(3) integrin were shown to inhibit bone resorption in vitro and in vivo, suggesting that this integrin may play an important role in regulating osteoclast function. Several lines of evidence have demonstrated that a number of signaling molecules are involved in the alpha(v)beta(3) integrin-dependent signaling pathway, including c-Src, Pyk2, c-Cbl, and p130(Cas). In this article, we review the history of "alpha(v)beta(3) integrin and osteoclasts" and discuss the involvement of alpha(v)beta(3) integrins in osteoclast function at tissue, cellular, and molecular levels. A better understanding of the role of alpha(v)beta(3) integrin in osteoclastic bone resorption would provide opportunities for developing new therapeutics to treat human bone diseases, including rheumatoid arthritis, osteoporosis, and periodontal disease.

PubMed Disclaimer

References

    1. J Electron Microsc (Tokyo). 2003;52(6):527-33 - PubMed
    1. J Cell Biol. 2001 Jan 8;152(1):181-95 - PubMed
    1. Endocrinology. 1998 Mar;139(3):1401-10 - PubMed
    1. Endocrinology. 1998 Mar;139(3):1411-9 - PubMed
    1. Exp Cell Res. 1991 Aug;195(2):368-75 - PubMed

Substances

LinkOut - more resources